Literature DB >> 19917382

Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China.

C Pan1, Y Shi, J J Zhang, Y L Deng, H Zheng, Z J Zhu, Z Y Shen.   

Abstract

OBJECTIVE: We sought to review the etiopathogenesis, diagnosis, and surgical options for 253 patients with portal vein thrombosis (PVT) undergoing orthotopic liver transplantation (OLT) to assess the the impact of PVT on outcomes.
METHODS: We retrospectively analyzed the data from 2508 adult patients undergoing 2614 OLTs in our center from September 1998 to July 2007. PVT was scored according to the operative findings and Yerdel grading of PVT. No prisoners were used as donors for this study.
RESULTS: Two hundred fifty-three patients were diagnosed with PVT (10.09%): there were 104 grade I; 114, grade II; 29, grade III; and 6, grade IV PVT. Sex and previous splenectomy increased the risk for PVT. In grade I and II cases, we performed simple thrombectomy, eversion thrombectomy, or improved eversion thrombectomy (IET, innovated by our center), producing smooth postoperative recoveries with a 0% in-hospitality mortality. In grade III cases, 18 underwent successful IET. Of 11 subjects who had eversion thrombectomy, six failed, and the distal superior mesentery vein or dilated splanchnic collateral tributary had to be used as the inflow vessel in four patients, and portal vein arterialization were performed in the other two patients, all of whom experienced a smooth postoperative recovery except one who died of hepatic failure and pulmonary infection 2 weeks after the operation. The in-hospitality mortality was 3.45%. In grade IV cases, three underwent successful IET, but another three cases failed, with two of them requiring a renal vein as the inflow vessel, and other one undergoing portocaval hemitransposition, with one postoperative death due to hepatic failure and another of cancer recurrence, an in-hospitality mortality rate of 33.33%. The transfusion requirement among PVT patients was significantly higher than that in non-PVT patients (9.32 +/- 3.12 U vs 6.02 +/- 2.40 U; P < .01). Blood loss in PVT patients who underwent the IET technique was significantly lower than that for an eversion thrombectomy (2800.36 +/- 930.52 mL vs 5700.21 +/- 162.50 mL P < .05). The overall actuarial 1-year survival rate in PVT patients was similar to the controls (86.56% vs 89.40%; P > .05).
CONCLUSION: OLT was successfully performed for PVT patients. The grade of PVT decided the surgical strategy. Similar 1-year survival rates were attained between PVT patients and controls undergoing OLT.

Entities:  

Mesh:

Year:  2009        PMID: 19917382     DOI: 10.1016/j.transproceed.2009.06.215

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  14 in total

1.  An early single-center experience of portal vein thrombosis in living donor liver transplantation: clinical feature, management and outcome.

Authors:  Joo Dong Kim; Dong Lak Choi; Young Seok Han
Journal:  J Korean Surg Soc       Date:  2011-07-11

Review 2.  Review of the surgical approach to prevent small-for-size syndrome in recipients after left lobe adult LDLT.

Authors:  Vikram Raut; Ruslan Alikhanov; Jacques Belghiti; Shinji Uemoto
Journal:  Surg Today       Date:  2013-08-01       Impact factor: 2.549

3.  Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization.

Authors:  Wei Lai; Shi-Chun Lu; Guan-Yin Li; Chuan-Yun Li; Ju-Shan Wu; Qing-Liang Guo; Meng-Long Wang; Ning Li
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

Review 4.  From portal to splanchnic venous thrombosis: What surgeons should bear in mind.

Authors:  Quirino Lai; Gabriele Spoletini; Rafael S Pinheiro; Fabio Melandro; Nicola Guglielmo; Jan Lerut
Journal:  World J Hepatol       Date:  2014-08-27

5.  Outcomes of Living Donor Liver Transplantation for Patients with Preoperative Portal Vein Problems.

Authors:  Mohamed Abdel Wahab; Ahmed Shehta; Mohamed Elshoubary; Tarek Salah; Omar Fathy; Ahmed Sultan; Ahmed Nabieh Elghawalby; Mahmoud Ali; Amr Mohamed Yassen; Mohamed Elmorshedi; Mohamed Eldesoky; Ahmed Monier; Rami Said
Journal:  J Gastrointest Surg       Date:  2018-07-23       Impact factor: 3.452

6.  ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy.

Authors:  Seung Duk Lee; Seong Hoon Kim; Sun-Young Kong; Young-Kyu Kim; Soon-Ae Lee; Sang-Jae Park
Journal:  HPB (Oxford)       Date:  2014-01-28       Impact factor: 3.647

Review 7.  Portal vein thrombosis: should anticoagulation be used?

Authors:  Stephen E Congly; Samuel S Lee
Journal:  Curr Gastroenterol Rep       Date:  2013-02

Review 8.  Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment.

Authors:  Francesca R Ponziani; Maria A Zocco; Chiara Campanale; Emanuele Rinninella; Annalisa Tortora; Luca Di Maurizio; Giuseppe Bombardieri; Raimondo De Cristofaro; Anna M De Gaetano; Raffaele Landolfi; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

9.  Liver transplantation in Indian Armed Forces-initial experience.

Authors:  Anupam Saha; Cs Naidu; Gs Ramesh; Joy Chatterjee; Pankaj Puri; Bhaskar Nandi; Pradhi Nambiar; Renu Madan
Journal:  Med J Armed Forces India       Date:  2012-04-21

10.  Prognosis of patients with hepatocellular carcinoma and hypersplenism after surgery: a single-center experience from the People's Republic of China.

Authors:  Cong Li; Hong Zhao; Jianjun Zhao; Zhiyu Li; Zhen Huang; Yefan Zhang; Xinyu Bi; Jianqiang Cai
Journal:  Onco Targets Ther       Date:  2014-06-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.